# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 90


After regulation 118 amendment of regulation 133 (amendment of regulation 133 (application for renewal of registration)) insert—
“Amendment of regulation 134 (failure to place on the market etc.)
118A. (1) Regulation 134 (failure to place on the market etc.) is amended as follows.
(2) In paragraph (1) after “in the United Kingdom” insert “(or, in the case of a THR(GB) granted after an application under the unfettered access route, in Great Britain)”.
(3) In paragraph (2) after “in the United Kingdom” insert “(or, in the case of a THR(GB) granted after an application under the unfettered access route, in Great Britain)”.”.

---
Source: https://www.legislation.gov.uk/ukdsi/2020/9780348213980/schedule/2/paragraph/90 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-90
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.